Kairos Pharma KAPA
NYSE KAPA
$0.56 -0.02 (-2.97%)
As of: Oct 22, 2026 · 12:10 PM EDT

Kairos Pharma (KAPA) Notes Payables (2024)

Updated

Kairos Pharma (KAPA) reported Notes Payables of $792,000 for Q3 2024.

Analysis

Kairos Pharma (KAPA) Notes Payables (2024) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,168.10 Bn 1,136.68 Bn 19.71 Bn
2 Johnson & Johnson 643.43 Bn 561.95 Bn 17.26 Bn
3 AbbVie 500.92 Bn 474.03 Bn 12.70 Bn
4 Merck 360.47 Bn 314.85 Bn 12.21 Bn
5 Novartis Ag 302.41 Bn 266.40 Bn 11.24 Bn
6 Astrazeneca 267.36 Bn 241.05 Bn 12.86 Bn
7 Amgen 241.30 Bn 196.70 Bn 7.24 Bn
8 Gilead Sciences 192.97 Bn 167.17 Bn 6.22 Bn
9 Pfizer 171.65 Bn 118.30 Bn 10.94 Bn
10 Kairos Pharma 10.31 Mn -2.10 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2024 792,000.00
API Access

Kairos Pharma Notes Payables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=notes-payables&ticker=KAPA&period=max&api_key=YOUR_API_KEY